Better Blood Sugar Control Doesn't Always Mean Easier School Life, New Study Shows
A large survey of German families reveals that while automated insulin delivery systems improve glycemic control in children with Type 1 diabetes, they don't necessarily make school participation easier—and may increase how often parents are contacted by schools.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Automated insulin delivery (AID) systems lowered HbA1c levels in children and teens, but this improvement didn't translate into better school participation
- Between 10-28% of secondary school students and 24-61% of primary school students still couldn't participate in certain school activities, regardless of technology use
- AID users experienced more frequent school phone calls and early pick-ups than other children, suggesting the systems may increase rather than decrease school-related disruptions
- Most primary school children received external diabetes support during school hours, yet schools still lack standardized, integrated diabetes care systems
What the Study Looked At
Researchers in Germany surveyed nearly 800 parents of school-aged children with Type 1 diabetes to understand how modern insulin delivery technology affects daily school life. The study included children ranging from ages 6 to 16, attending primary schools, secondary schools, and specialized schools. Parents answered detailed questions about their child's diabetes management at school, school participation, and how often school disruptions—like phone calls or early pick-ups—occurred.
Better Blood Sugar, but School Life Still Challenging
Children using automated insulin delivery systems did achieve better glycemic control, as measured by lower HbA1c levels. However, this medical improvement didn't automatically make school participation easier. Significant portions of students still couldn't take part in certain school activities: roughly one in four to six of primary school children and one in four to three of secondary school students were unable to participate in activities they wanted to join.
The difference between age groups was notable. Teenagers were more likely to participate in school activities overall compared to younger children, but substantial gaps remained for both groups.
More Technology, More School Contact
Surprisingly, using an AID system was associated with more frequent school phone calls and early pick-ups—not fewer. This suggests that even with improved blood sugar control, the systems may require additional monitoring or communication with families during the school day. The reasons for increased contact weren't fully explored in the study, but the finding highlights a disconnect between technical improvements and real-world school life.
Three-quarters of primary school children received some form of external support during school hours, yet despite this resource use, standardized diabetes care in schools remained fragmented.
The Bigger Picture: Work and Family Life
The study also found that approximately one-third of parents reduced their working hours immediately after their child's diabetes diagnosis. This underscores the ongoing demand on families beyond what technology alone can address. Even in Germany, where healthcare resources are robust, the school system hasn't developed integrated, standardized approaches to diabetes support that would allow families and children greater independence and stability.
What This Means
This research reveals an important gap: better blood sugar control is valuable and worth pursuing, but it's only one piece of the puzzle. Families and young people with Type 1 diabetes face real barriers to full school participation that improved technology doesn't automatically solve. The findings suggest that alongside advances in medical devices, schools need clearer protocols, training, and support systems to help children and teens with diabetes participate fully in school life without constant interruptions.
Evidence label
Source: Hormone research in paediatrics. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
From Type1Cure
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Research summaryDiagnosis & Early DetectionA Simple Blood Test May Help Doctors Assess How Severe Your DKA IsPubMed indexed literature
- Research summaryDiagnosis & Early DetectionA New Approach to Finding Type 1 Diabetes Early: Testing During Routine CheckupsPubMed indexed literature
- Research summaryDiagnosis & Early DetectionSingle Autoantibody: What It Means When Your Child Tests Positive for One Type 1 MarkerPubMed indexed literature
- Research summaryDiagnosis & Early DetectionKetosis-Prone Type 2 Diabetes: New Clues to an Immune Mix-UpPubMed indexed literature
- Research summaryDiagnosis & Early DetectionWhy Screening for Type 1 Diabetes Before Symptoms MatterPubMed indexed literature
- Research summaryDiagnosis & Early DetectionTesting for Type 1 Before Symptoms Appear: What a Real-World Pilot LearnedPubMed indexed literature